1-[3-Chloro-5-(trifluoromethyl)-2-pyridinyl]--4-piperidinecarboxylic acid, 95.0%, 2g

Ethyl 2,5-dioxo-2,5-dihydro-1H-pyrrole-1-carboxylate, 95.0%, 1g

4-(Boc-amino)-L-phenylalanine, 97.0%, 1g

3-(5-Chloro-1-methyl-1H-benzoimidazol-2-yl)-propionic acid, 95.0%, 500mg

Adamantane>99.0%(GC)500g

2-Fluoro-5-iodobenzoic acid, 97.0%, 1g

4-(Trifluoromethyl)cyclohexan-1-amine hydrochloride, 98%, 100g

tert-Butyl 1-(2-chloro-4-fluorobenzyl)piperidin-4-ylcarbamate, 95.0%, 1g

tert-Butyl 3-methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate, 98%, 5g

Plan strain-free PLPOLi 100x/1.25 oil immersion IOS objective for iScope transmitted polarization, 0.17 mm cover glass correction. Working distance 0.13 mm

2-Bromo-5-isopropylthiazole, 95.0%, 10g

3,6,9,12-Tetraoxatetradecane-1,14-diol, 1-4-methylbenzenesulfonate, 98%, 500mg

6-Bromo-3H-[1,2,3]triazolo[4,5-b]pyridine, 95.0%, 250mg